ReShape Lifesciences Inc RSLS Valuation Ratios and Share Stats

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NASDAQ
ReShape Lifesciences Inc (RSLS)
ReShape Lifesciences Inc (RSLS) Financials

ReShape Lifesciences Inc (RSLS)

4.482

0.04

(0.95%)

Closed 28 January 8:00AM

Delayed by 15 minutes

4.482

0.00

( 0.00% )

Pre Market: 9:41PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-44.016	-52.723	-89.547	-93.251	-79.549	-190.93	-141.327	-104.444
Return on Equity (%)	-446.585	-69.937	-155.039	-163.531	-120.25	-244.133	-185.848	-220.593
Return on Invested Capital (%)	-138.623	-58.656	-131.586	-157.369	-105.33	-104.969	-105.578	-288.754
Operating Margin (%)	-589.154	-349.304	-408.241	-709.875	-776.7	-450.051	-413.532	-130.618
Net Profit Margin (%)	-603.212	-350.666	-410.724	-721.609	-776.7	-455.39	-411.157	-131.217
Book Value Per Share	3.834	2.006	0.557	2.052	0.6	1.416	0.151	0.507
Earnings Per Share	-1.22	-1.986	-1.59	-3.065	-1.587	-3.473	-2.045	-0.867
Cash Per Share	4.351	1.206	0.901	1.82	0.503	1.277	0.171	0.339
Working Capital Per Share	4.38	2.385	0.486	1.846	0.359	1.286	0.108	0.496
Operating Profit Per Share	0.046	0.309	0.181	0.105	0.119	0.579	0.396	0.434
EBIT Per Share	-1.22	-1.986	-1.59	-3.065	-1.587	-3.479	-2.062	-0.863
EBITDA Per Share	-1.22	-1.986	-1.59	-3.065	-1.587	-3.479	-2.062	-0.863
Free Cash Flow Per Share	-1.211	-1.946	-1.56	-3.102	-1.609	-3.396	-2.135	-0.875

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	16.77M	17.5M	23.51M	7.72M	7.77M	17.83M	N/A	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-115.566	N/A	N/A	N/A	-112.088	N/A	N/A
Net Profit Margin (%)	N/A	-116.397	N/A	N/A	N/A	-112.809	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	3.19M
Price to Earnings Ratio	-0.28
Price to Sales Ratio	0.37
Price to Cash Ratio	0.72
Price to Book Ratio	0.48
Dividend Yield	-

Share Statistics

Shares Outstanding	712.68k
Average Volume (1 week)	15.83k
Average Volume (1 Month)	23.55k
52 Week Change	-63.20%
52 Week High	29.00
52 Week Low	4.09

More Ratios Coming Soon!

ReShape Lifesciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions